Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 148.63 Million INR | -19.16% |
| 2022 | 183.85 Million INR | 52.33% |
| 2021 | 120.69 Million INR | 128.23% |
| 2020 | 52.88 Million INR | -42.97% |
| 2019 | 92.73 Million INR | 18.67% |
| 2018 | 78.14 Million INR | 21.58% |
| 2017 | 64.27 Million INR | 76.84% |
| 2016 | 36.34 Million INR | 494.66% |
| 2015 | 6.11 Million INR | 6.79% |
| 2014 | 5.72 Million INR | 34.86% |
| 2013 | 4.24 Million INR | -0.07% |
| 2012 | 4.24 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 170.37 Million INR | 467.33% |
| 2024 Q1 | -46.38 Million INR | -131.21% |
| 2023 FY | 148.63 Million INR | -19.16% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 237.97 Million INR | 0.0% |
| 2023 Q4 | 148.63 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 183.85 Million INR | 0.0% |
| 2022 FY | 183.85 Million INR | 52.33% |
| 2022 Q3 | - INR | 0.0% |
| 2021 Q4 | 93.33 Million INR | 0.0% |
| 2021 Q2 | 59.57 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 120.69 Million INR | 128.23% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 54.69 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 52.88 Million INR | -42.97% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 52.88 Million INR | 0.0% |
| 2019 Q4 | 92.73 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 92.73 Million INR | 18.67% |
| 2019 Q2 | 44.85 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q2 | 64.46 Million INR | 0.0% |
| 2018 Q4 | 78.14 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 78.14 Million INR | 21.58% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 65.66 Million INR | 0.0% |
| 2017 FY | 64.27 Million INR | 76.84% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 64.27 Million INR | 0.0% |
| 2016 Q2 | 22.28 Million INR | 0.0% |
| 2016 Q4 | 36.34 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 36.34 Million INR | 494.66% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 5.61 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 6.11 Million INR | 6.79% |
| 2015 Q4 | 6.11 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 5.72 Million INR | 34.86% |
| 2014 Q4 | 5.72 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 5.66 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 FY | 4.24 Million INR | -0.07% |
| 2013 Q2 | 4.36 Million INR | 0.0% |
| 2013 Q4 | 4.24 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2012 FY | 4.24 Million INR | 0.0% |
| 2012 Q4 | 4.24 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -478.307% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 85.083% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -608.104% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -177.054% |
| Sunil Healthcare Limited | 902.83 Million INR | 83.537% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -6884.539% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.959% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 85.201% |
| Patidar Buildcon Limited | 25.57 Million INR | -481.226% |
| Roopa Industries Limited | 493.08 Million INR | 69.857% |
| Smruthi Organics Limited | 485.72 Million INR | 69.4% |
| Trident Lifeline Limited | 331.26 Million INR | 55.132% |
| PANJON LTD. | 25.38 Million INR | -485.553% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 28.694% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 8.067% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -892.263% |
| Anuh Pharma Limited | 1.54 Billion INR | 90.378% |
| Crestchem Limited | 23.94 Million INR | -520.666% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1008.773% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -25.721% |
| Tyche Industries Limited | 101.64 Million INR | -46.231% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 92.015% |
| Trimurthi Limited | 101.36 Thousand INR | -146536.74% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 26.411% |
| Norris Medicines Limited | 278.17 Million INR | 46.569% |
| Zenlabs Ethica Limited | 301.35 Million INR | 50.679% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 49.007% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 91.055% |
| Parmax Pharma Limited | 117.56 Million INR | -26.422% |
| Veerhealth Care Limited | 62.78 Million INR | -136.749% |
| Deccan Health Care Limited | 111.33 Million INR | -33.498% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 91.329% |
| Makers Laboratories Limited | 569.18 Million INR | 73.887% |
| Lactose (India) Limited | 536.39 Million INR | 72.291% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 82.16% |
| Zenith Healthcare Limited | 24.03 Million INR | -518.394% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | 4.149% |
| Bacil Pharma Limited | 1.12 Million INR | -13064.836% |
| PRAVEG LIMITED | 767.53 Million INR | 80.635% |
| Denis Chem Lab Limited | 289.82 Million INR | 48.716% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 91.34% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 26.271% |
| Colinz Laboratories Limited | 24.1 Million INR | -516.598% |
| Godavari Drugs Limited | 957.86 Million INR | 84.483% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -49609.365% |
| Zenotech Laboratories Limited | 156.64 Million INR | 5.118% |
| Panchsheel Organics Limited | 340.2 Million INR | 56.311% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 69.566% |
| Phaarmasia Limited | 211.49 Million INR | 29.724% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 90.095% |
| Medi-Caps Limited | 63.01 Million INR | -135.862% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -26.253% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 24.695% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 86.857% |
| Mercury Laboratories Limited | 171.18 Million INR | 13.177% |
| Gennex Laboratories Limited | 535.21 Million INR | 72.23% |
| BDH Industries Limited | 312.53 Million INR | 52.443% |
| Coral Laboratories Limited | 281.83 Million INR | 47.264% |
| Concord Drugs Limited | 249.88 Million INR | 40.52% |
| Bharat Parenterals Limited | 2.65 Billion INR | 94.405% |
| Beryl Drugs Limited | 85.63 Million INR | -73.561% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 15.149% |
| Evoq Remedies Limited | 116.23 Million INR | -27.874% |
| Add-Shop E-Retail Limited | 159.2 Million INR | 6.641% |
| Transchem Limited | 6.72 Million INR | -2111.771% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -1575.282% |
| Parnax Lab Limited | 1.17 Billion INR | 87.304% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -254.119% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 85.947% |
| Cian Healthcare Limited | 1.03 Billion INR | 85.631% |
| Trinity League India Limited | 876 Thousand INR | -16867.009% |
| Syschem (India) Limited | 1.07 Billion INR | 86.119% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 92.725% |
| Natural Capsules Limited | 1.47 Billion INR | 89.938% |
| Auro Laboratories Limited | 433.09 Million INR | 65.682% |